XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Lossses)
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2019   53,473,620        
Balance at beginning of period at Dec. 31, 2019 $ 520,988 $ 750 $ 638,917 $ 221,841 $ (3,978) $ (336,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (106,647)     (106,647)    
Foreign currency translation (1,636)       (1,636)  
Stock-based compensation (in shares)   141,223        
Stock-based compensation (917) $ 3 (920)      
Stock repurchase (in shares)   (766,122)        
Stock repurchase (10,051)         (10,051)
Common stock dividends (3,885)     (3,885)    
Unrealized gain (loss) on derivative instruments (3,883)       (3,883)  
Balance at end of period (in shares) at Mar. 31, 2020   52,848,721        
Balance at end of period at Mar. 31, 2020 393,969 $ 753 637,997 111,309 (9,497) (346,593)
Balance at beginning of period (in shares) at Dec. 31, 2019   53,473,620        
Balance at beginning of period at Dec. 31, 2019 520,988 $ 750 638,917 221,841 (3,978) (336,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (106,793)          
Foreign currency translation (1,318)          
Unrealized gain (loss) on derivative instruments (1,619)          
Balance at end of period (in shares) at Jun. 30, 2020   52,906,115        
Balance at end of period at Jun. 30, 2020 393,217 $ 753 639,330 106,656 (6,915) (346,607)
Balance at beginning of period (in shares) at Mar. 31, 2020   52,848,721        
Balance at beginning of period at Mar. 31, 2020 393,969 $ 753 637,997 111,309 (9,497) (346,593)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (146)     (146)    
Foreign currency translation 318       318  
Stock-based compensation (in shares)   57,394        
Stock-based compensation 1,333   1,333      
Stock repurchase (14)         (14)
Common stock dividends (4,507)     (4,507)    
Unrealized gain (loss) on derivative instruments 2,264       2,264  
Balance at end of period (in shares) at Jun. 30, 2020   52,906,115        
Balance at end of period at Jun. 30, 2020 393,217 $ 753 639,330 106,656 (6,915) (346,607)
Balance at beginning of period (in shares) at Dec. 31, 2020   52,536,482        
Balance at beginning of period at Dec. 31, 2020 404,879 $ 755 644,695 107,233 7,633 (355,437)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 3,217     3,217    
Foreign currency translation (303)       (303)  
Stock-based compensation (in shares)   101,083        
Stock-based compensation 2,032 $ 1 2,031      
Stock repurchase (in shares)   (1,038,674)        
Stock repurchase (19,321)         (19,321)
Common stock dividends (3,967)     (3,967)    
Unrealized gain (loss) on derivative instruments 14,530       14,530  
Stock option exercises (in shares)   112,400        
Stock option exercises 1,235 $ 1 1,234      
Balance at end of period (in shares) at Mar. 31, 2021   51,711,291        
Balance at end of period at Mar. 31, 2021 402,302 $ 757 647,960 106,483 21,860 (374,758)
Balance at beginning of period (in shares) at Dec. 31, 2020   52,536,482        
Balance at beginning of period at Dec. 31, 2020 404,879 $ 755 644,695 107,233 7,633 (355,437)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 15,469          
Foreign currency translation 364          
Unrealized gain (loss) on derivative instruments 23,161          
Balance at end of period (in shares) at Jun. 30, 2021   50,464,034        
Balance at end of period at Jun. 30, 2021 399,980 $ 758 650,358 114,445 31,158 (396,739)
Balance at beginning of period (in shares) at Mar. 31, 2021   51,711,291        
Balance at beginning of period at Mar. 31, 2021 402,302 $ 757 647,960 106,483 21,860 (374,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 12,252     12,252    
Foreign currency translation 667       667  
Stock-based compensation (in shares)   37,147        
Stock-based compensation 2,184 $ 1 2,183      
Stock repurchase (in shares)   (1,304,214)        
Stock repurchase (21,981)         (21,981)
Common stock dividends (4,290)     (4,290)    
Unrealized gain (loss) on derivative instruments 8,631       8,631  
Stock option exercises (in shares)   19,810        
Stock option exercises 215   215      
Balance at end of period (in shares) at Jun. 30, 2021   50,464,034        
Balance at end of period at Jun. 30, 2021 $ 399,980 $ 758 $ 650,358 $ 114,445 $ 31,158 $ (396,739)